Strokes cause changes in gene activity in affected small blood vessels in the brain, changes that may be targetable with existing or future drugs to mitigate brain injury or improve stroke recovery, according to Weill Cornell Medicine scientists.
Culminating a year of planning by the Healthcare Students Association in the Cornell Jeb E. Brooks School of Public Policy's Sloan Program in Health Administration, a case competition attracted 40 teams representing the nation’s top graduate programs in health care and related fields.
In 2022-2023, the Center for Teaching Innovation awarded five Innovative Teaching & Learning Awards to Cornell faculty. With a goal of facilitating vibrant, challenging, and reflective learning experiences at Cornell, these awards sponsor projects across the colleges that explore new tools and emerging technologies, approaches, and teaching strategies. CTI is now accepting pre-applications for the 2023-2024 Innovative Teaching and Learning Awards – the deadline is April 17.
Can humans endure long-term living far from our home planet? Maybe, according to a new theory that describes the need for gravity, oxygen, obtaining water, developing agriculture and handling waste.
Using a biomaterials-based organoid, a multi-institution team led by Matt DeLisa of Cornell Engineering was able to assess the strength of the immune response to a glycoengineered vaccine in days, instead of months.
People with autism spectrum disorder can be classified into four distinct subtypes based on their brain activity and behavior, according to a study from Weill Cornell Medicine investigators.
A Cornell multidisciplinary research center that studies chronic fatigue syndrome has received a five-year, $9.5 million grant from the National Institutes of Health – funding that will enable experts to continue work on the mysterious and debilitating condition.
A team has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including omicron. Their discovery could lead to more potent vaccines and new antibody-based treatments.
